Corrado Advisors’s Genomic Health, Inc. GHDX Stock Holding History

Corrado Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-25,395	Closed	-$734K	–	118
2016 Q3	$734K	Sell	25,395 -15,300	-38%	-$426K	0.47%	52
2016 Q2	$1.05M	Sell	40,695 -5,665	-12%	-$150K	0.68%	39
2016 Q1	$1.15M	Sell	46,360 -2,335	-5%	-$64.1K	0.73%	34
2015 Q4	$1.71M	Sell	48,695 -17,970	-27%	-$481K	1.01%	30
2015 Q3	$1.41M	Sell	66,665 -8,625	-11%	-$222K	0.8%	30
2015 Q2	$2.09M	Buy	+75,290	New	+$2.12M	0.94%	32

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Corrado Advisors's GHDX Position: Q4 2016 in Review

Corrado Advisors sold out of Genomic Health, Inc. (GHDX) in Q4 2016, closing a stake of 25,395 shares — an estimated $734K sold.

Corrado Advisors first reported a position in GHDX in Q2 2015 and held it in 6 quarters. The position peaked at $2.09M in Q2 2015. 133 funds tracked by Wall St. Rank hold GHDX as of Q4 2016.

Corrado Advisors reported no remaining Genomic Health, Inc. position as of Q4 2016 after selling out during the quarter.
Corrado Advisors sold 25,395 Genomic Health, Inc. shares in Q4 2016, an estimated $734K.
Corrado Advisors first reported a position in Genomic Health, Inc. in Q2 2015 and held it in 6 quarters.
Corrado Advisors's Genomic Health, Inc. position peaked at $2.09M in Q2 2015.
133 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2016.

Based on Corrado Advisors's 13F filing for Q4 2016, filed 10 Jan 2017.